Reporting Manager
Ardsley Advisory Partners LP
Symbol
ASBP
Shares outstanding
138,530,928 shares
Disclosed Ownership
10,750,000 shares
Ownership
7.8%
Form type
SCHEDULE 13G
Filing time
12 Feb 2026, 13:00:30 UTC
Date of event
31 Dec 2025

Quoteable Key Fact

"ARDSLEY ADVISORY PARTNERS LP disclosed 7.8% ownership in Aspire Biopharma Holdings, Inc. Common Stock (ASBP) on 31 Dec 2025."

Quick Takeaways

  • ARDSLEY ADVISORY PARTNERS LP filed SCHEDULE 13G for Aspire Biopharma Holdings, Inc. Common Stock (ASBP).
  • Disclosed ownership: 7.8%.
  • Date of event: 31 Dec 2025.

What Changed

  • No earlier schedule filing is available for direct comparison.
  • Current filing was accepted on 12 Feb 2026, 13:00.

Why This Matters

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Source Evidence

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting Managers (6)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Ardsley Advisory Partners LP 7.8% 10,750,000 0 10,750,000 /s/ Steve Napoli Steve Napoli/ Member
Ardsley Advisory Partners GP LLC 7.8% 10,750,000 0 10,750,000 /s/ Steve Napoli Steve Napoli/ Member
Ardsley Partners I GP LLC 7.8% 10,750,000 0 10,750,000 /s/ Steve Napoli Steve Napoli/ Member
Ardsley Partners Advanced Healthcare Fund, L.P. 6.7% 9,229,100 0 9,229,100 /s/ Steve Napoli Steve Napoli/ Member
Ardsley Partners Fund II, L.P. 1.1% 1,520,900 0 1,520,900 /s/ Steve Napoli Steve Napoli/ Member
Philip J. Hempleman 7.8% 10,750,000 0 10,750,000 /s/ Steve Napoli* Steve Napoli/Attorney-in Fact for Philip J. Hempleman
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .